APA (7th ed.) Citation

MJ, R., J, L., TP, L., DP, L., JS, B., C, L., . . . B, L. (2020). Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(6), 1361. https://doi.org/10.1093/cid/ciaa303

Chicago Style (17th ed.) Citation

MJ, Rybak, et al. "Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus Aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 71, no. 6 (2020): 1361. https://doi.org/10.1093/cid/ciaa303.

MLA (9th ed.) Citation

MJ, Rybak, et al. "Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus Aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 71, no. 6, 2020, p. 1361, https://doi.org/10.1093/cid/ciaa303.